Dansk retningslinje for M-komponent analyser GUIDELINES DSKB/DMSG 2017 I 2012 udgav Dansk Selskab for Klinisk Biokemi (DSKB) og
![Distribution of k/l ratio in control, polyclonal gammoapthy, multiple... | Download Scientific Diagram Distribution of k/l ratio in control, polyclonal gammoapthy, multiple... | Download Scientific Diagram](https://www.researchgate.net/publication/26788073/figure/fig2/AS:601596924801032@1520443292695/Distribution-of-k-l-ratio-in-control-polyclonal-gammoapthy-multiple-myeloma-with-k-and.png)
Distribution of k/l ratio in control, polyclonal gammoapthy, multiple... | Download Scientific Diagram
![Distribution of k/l ratio in control, polyclonal gammoapthy, multiple... | Download Scientific Diagram Distribution of k/l ratio in control, polyclonal gammoapthy, multiple... | Download Scientific Diagram](https://www.researchgate.net/profile/Pavai-Sthaneshwar/publication/26788073/figure/fig2/AS:601596924801032@1520443292695/Distribution-of-k-l-ratio-in-control-polyclonal-gammoapthy-multiple-myeloma-with-k-and_Q640.jpg)
Distribution of k/l ratio in control, polyclonal gammoapthy, multiple... | Download Scientific Diagram
Til SFR for klinisk biokemi Konsekvenser ved implementering af ny dansk guideline for diagnostisk og opfølgning af M- komponent
![The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12882-020-01771-3/MediaObjects/12882_2020_1771_Fig1_HTML.png)